Efficacy of Paroxetine controlled release and Escitalopram in patients with Panic disorder : A Randomised Controlled Trial. - NI

Dr Sahil0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年9月18日

试验速览

暂无简介。

•Inclusion Criteria:
•1)Patients meeting the diagnostic criteria of panic disorder with or without agoraphobia as per DSM-5
•2)Male or female patients in the age group of 18-65 years (both inclusive).
•3)Patients willing to give written informed consent.
•4)Symptom onset atleast 3 months prior to enrolment in study (in case of newly diagnosed patients) or off medication for atleast 3 months prior to enrolment in study (in already diagnosed patients of panic disorder).
•Patients with Panic Disorder Severity Scale Score = 8 on screening.

•Exclusion Criteria:
•1)Patients with Montgomery-Asberg Depression Rating Scale (MADRS) score = 20 and Generalized Anxiety Disorder Scale 7 (GAD-7) score = 10.
•2)Pregnant women or nursing mothers.
•3)Women planning to conceive. (in patient consent form it has been included that patient will not conceive for next 8 weeks)
•4)Patient’s symptoms are associated with or attributable to an identifiable cause such as Hyperthyroidism, Asthma, Cardiovascular diseases (like angina, congestive heart failure etc ) or Substance use disorder.
•5)Patients with known history of dyslipidemia.
•6)Patients with diabetes mellitus, uncontrolled hypertension, heart block, bradycardia (pulse < 60 / min), epilepsy or other co-existing diseases.
•7)History of acute myocardial infarction or stroke.
•8)Patients having history suggestive of psychosis or dementia.

发起方

Dr Sahil